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Abstract
Background: Visceral leishmaniasis (VL) is a neglected tropical disease (NTD), caused by the intracellular protozoan
parasites Leishmania donovani and Leishmania infantum. Symptomatic VL is considered fatal when left untreated. At
present, there is no effective vaccine licensed for human use and available chemotherapies have limitations.
Understanding the local immune mechanisms required for the control of infection is a key factor for developing
effective vaccines and therapeutics.
Methods: We have investigated the development of the typical granulomatous lesions in the liver in experimental VL
over time, together with the local immune responses. BALB/c mice were infected intravenously with a dose of 2 × 107 L.
donovani amastigotes (MHOM/ET/67/HU3) and sacrificed at 15, 35 and 63 days post-infection (dpi). Histopathology and
immunohistochemical techniques were used for the detection of Leishmania antigen, selected cell types including B
and T lymphocytes, macrophages and neutrophils (CD45R-B220+, CD3+, F4/80+ and Ly-6G+) and iNOS.
Results: Granulomatous lesions were identified as early as 15 dpi in the livers of all infected animals. Three categories
were used to classify liver granulomas (immature, mature and clear). Clear granulomas were exclusively detected from
35 dpi onwards. Kupffer cells (F4/80+) were predominant in immature granulomas, regardless of the dpi. Nonetheless,
the highest expression was found 63 dpi. Positive staining for iNOS was mainly observed in the cytoplasm of fused
Kupffer cells and the highest expression observed at 35 dpi. T cells (CD3+) and B cells (CD45R-B220+) were
predominant in more advanced granuloma stages, probably related to the establishment of acquired immunity.
Neutrophils (Ly-6G+) were predominantly observed in mature granulomas with the highest expression at 15 dpi.
Neutrophils were lower in numbers compared to other cell types, particularly at later time points.
Conclusions: Our results reflect the role of macrophages during the early stage of infection and the establishment of a
lymphocytic response to control the infection in more advanced stages.
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Background
Leishmaniasis is one of the most prevalent parasitic
public health problems worldwide [1, 2]. This term
includes cutaneous leishmaniasis (CL), mucocutaneous
leishmaniasis [3] and visceral leishmaniasis (VL) [2, 4].
VL is caused by the intracellular protozoan parasites
Leishmania donovani in Asia and Africa and Leishmania
infantum in Latin America and the Mediterranean
region [5]. VL has a high mortality rate if untreated and
is estimated to cause 0.2–0.4 million new cases and
20,000–40,000 deaths per year worldwide [1]. Parasites
are transmitted by female phlebotomine sandflies to
mammalian hosts. Humans are the only known reservoir
of L. donovani, while canines are the main reservoir for
L. infantum [6]. In the Mediterranean basin and Latin
America, VL is considered a zoonosis caused by L.
infantum. Northward spread of VL endemic foci in Italy
has been reported [7].
At present, there is no vaccine licensed for human use
against VL. Limitations of current chemotherapeutic
treatments include drug toxicity, long treatment courses,
challenging routes of drug administration, drug stability
in hot climates and geographical differences in clinical
responses to treatment [8, 9].
Understanding the immune mechanisms required for
control of infection within the varied tissue microenvi-
ronments that contain Leishmania-infected macro-
phages is a key factor for developing effective vaccines
and therapeutics. Due to the intrusive techniques re-
quired to analyse such responses in human VL patients,
current knowledge of host responses in tissues largely
derives from experimental animal models, which include
mice, hamsters and dogs. The granulomatous pathology
of leishmaniasis, across different disease manifestations
and in humans and animal hosts, has recently been
reviewed [10]. Many of the cellular and molecular com-
ponents of acquired immunity necessary for the forma-
tion, maintenance and effector function of granulomas
have been characterised through the use of gene-
targeted mice or in vivo administration of neutralizing
or depleting monoclonal antibodies [10–12]. Here we
characterized the local host and immune response in
hepatic tissue from L. donovani-infected BALB/c mice
over time, using histopathological and immunohisto-
chemical analyses.
Methods
Experimental design
A total of 24 BALB/c mice (Charles River, UK) were
used for this study. Leishmania donovani (MHOM/ET/
67/HU3) amastigotes were harvested from the spleen of
a Rag-1-knockout (B6) mouse (LSHTM breeding colony,
infected > 40 days), re-suspended in RPMI 1640 medium
without serum and used for the infection of 18 mice
through a 0.2 ml intravenous bolus injection into a tail
vein, corresponding to 2 × 107 amastigotes. One group
of 6 mice was left uninfected.
Groups of 6 mice were euthanized by cervical dis-
location at three different time points, 15 dpi (6 in-
fected mice + 6 uninfected mice), 35 dpi (6 infected
mice) and 63 dpi (6 infected mice). Livers were re-
moved and their weights recorded. Impression smears
were prepared and fixed in 100% methanol to allow
determination of parasite burden and confirm infec-
tion. A small piece of liver for each animal was cut off
and placed in zinc salt fixative [13] for 16 h and trans-
ferred to 70% ethanol for 4 h before processing into paraf-
fin wax. Liver tissue samples were also immersed in 10%
neutral buffered formalin solution and processed routinely
into paraffin wax.
Histopathology
Four-μm tissue sections were stained with Hematoxylin
and Eosin (H&E) and analysed under light microscopy
to identify lesions. The total number of granulomas to-
gether with the granuloma size (area) was calculated in
a full liver section per animal using a Nikon Eclipse Ni-
U microscope and digital image analysis software
(Nikon NIS Br, Nikon, Japan). Along with this, granu-
lomas in the liver were classified into three categories
according to cellular composition and evolution stage
within each time point. Category 1, corresponding to
“immature granulomas”, was defined as individual or
few fused Kupffer cells without or with few mono-
nuclear cells grouped loosely and harbouring a high
number of amastigotes. Category 2 or “mature granu-
lomas” were defined as tightly fused Kupffer cells sur-
rounded by cellular infiltrate, with or without evidence
of collagen deposition and with presence of some amas-
tigotes. Category 3 or “clear granulomas” were defined
as well formed granulomas with few fused Kupffer cells
surrounded by a cellular infiltrate, normally with evi-
dence of collagen deposition and without presence of
amastigotes.
Immunohistochemistry
The immunohistochemical techniques are summarised
in Table 1. Formalin or zinc salt fixed liver samples were
cut in 4 μm sections, dewaxed and rehydrated at 19 °C,
and placed in a fresh solution of 3% hydrogen peroxide
in methanol for 15 min to block endogenous peroxidase
activity. Samples were then washed in tap water. Epitope
demasking was not necessary for zinc salt fixed samples.
However, antigen retrieval in formalin fixed samples was
achieved with enzymatic digestion, using a solution of
2% proteinase K (Dako, Glostrup, Denmark) in tris-buff-
ered saline (0.05 mol/l Tris-HCl pH 7.5–7.7) or by heat di-
gestion (water-bath, pH 6.0 Dako buffer, 20 min, 95 °C)
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depending on the primary antibody used (Table 1). Run-
ning tap water was then used to wash the tissue sections
and the slides were then mounted onto Shandon cover-
plates (Thermo Fisher Scientific, Runcorn, Chesire,
United Kingdom) and loaded into Sequenza® trays
(Shandon Scientific). Once mounted, the slides were
washed with tris-buffered saline (TBS) (0.85% NaCl,
0.0605% Tris, adjusted to pH 7.5 using 1 M HCl) and
then 190 μl of Universal Blocker™ Blocking Buffer in
TBS (Thermo Fisher Scientific, Runcorn, Chesire,
United Kingdom) was added as blocking agent. After
20 min, 190 μl of the primary antibody was added. The
incubation time varied for each primary antibody used.
After two washes with TBS buffer, 190 μl of biotinylated
link antibody (Table 1) and link block were added,
followed by two further buffer washes, 30 min later.
Primary and secondary antibody binding was amplified
using Ultra-Sensitive ABC Peroxidase Rabbit IgG Stain-
ing Kit (Thermo Fisher Scientific, Runcorn, Chesire,
United Kingdom) and visualized using the Vector®
NovaRED™ Substrate Kit (Vector Laboratories,
Burlingame, California, USA). Unbound conjugate was
removed prior to Vector® NovaRED™ Substrate Kit
application with two buffer washes. Slides were then
washed in purified water, removed from the coverplates
and placed in a rack. Samples were rinsed with tap
water for 5 min, before being placed in Mayer’s
Haematoxylin counterstain, followed by a further wash
in tap water. Finally, sections were dehydrated, cleared
and mounted for analysis.
Image analysis
Immunolabelled sections were analysed using light
microscopy and digital image analysis (Nikon NIS Br,
Nikon Instruments Europe BV, Amsterdam, The
Netherlands). The slides were examined with the 40×
objective to give a final magnification of 400×, to as-
certain the percentage of immunostained area in the
lesion. The whole area of the granuloma was selected
as region of interest (ROI), and the area with immu-
nohistochemically positive reaction within the ROI
was calculated by the software after setting the
thresholds. The results are expressed as the percent-
age of positively immunolabelled area within the total
area of the granuloma.
Statistics
Chi-square test was applied to analyse differences be-
tween the number and category of granulomas per time
point in the liver. Student’s t-test was used to assess the
significance of the differences in the size between granu-
loma categories.
For IHC, Student’s t-test was performed to compare
the mean expression of each immune marker within
granuloma categories and time points. Differences
were considered significant at P < 0.05. The results of
immunohistochemical analyses are expressed as group
mean ± standard deviation (SD). All analyses were
conducted using SPSS 19 software package (SPSS
Inc., Chicago, IL, 60606, USA) and GraphPad Prism
7.0 (San Diego, USA).
Results
Confirmation of infection
The hepatic parasite burden 15 dpi, expressed in
Leishman-Donovan units (LDUs), was 456 ± 65 (group
mean ± SD), confirming previously observed levels of in-
fection. Liver weights (group mean ± SD) at 15 dpi, 35
dpi and 63 dpi were 1041 ± 90 mg, 1365 ± 107 mg and
1412 ± 71 mg, respectively.
Histopathology
Granulomas and aggregations of macrophages were
present in the livers of all infected animals from 15 dpi
onwards (Fig. 1). After the analysis of an entire section
of liver for each animal, we characterized (categories)
and measured a total of 2467 granulomas from the
infected animals. Statistically significant differences
Table 1 Antibodies and reagents used for immunohistochemistry
Primary antibody Antibody type Dilution Supplier Epitope demasking method Link antibody (dilution) Buffer
CD3 Rabbit vs Human CD3
(polyclonal)
1/500 Dako (A0452) (Glostrup,
Denmark)
Proteinase K (Dako) Goat vs Rabbit
(1/1000)
TBS
CD45R (B220) Rat vs Mouse CD45R
(B220) (monoclonal)
1/100 Invitrogen (RA3-6B2) (Thermo
Fisher, Darmstadt, Germany)
pH 6 citrate-buffer (Dako) Goat vs Rat (1/200) TBS
Ly-6G (Gr1) Rat vs Mouse Ly-6G
(Gr1) (monoclonal)
1/25 Invitrogen (RB6-8C5) pH 6 citrate-buffer (Dako) Goat vs Rat (1/200) TBS
F4/80 Rat vs Mouse F4/80
(monoclonal)
1/100 BioRad (MCA 4976)
(Watford, Hertfordshire, UK)
None (ZSF samples) Goat vs Rat (1/200) TBS
iNOS Rabbit vs Mouse iNOS
(polyclonal)
1/500 Merck Millipore (ABN26)
(Watford, Hertfordshire, UK)
None (ZSF samples) Goat vs Rabbit
(1/1000)
TBS
Anti-Leish Rabbit vs Leishmania spp. 1/50 ISCIII (Madrid, Spain) None Goat vs Rabbit
(1/1000)
TBS
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(P < 0.001) were found in the mean size of granulomas,
depending on their category (Table 2). Mature granu-
lomas were larger compared to the other two categories
(Immature vs mature: t = -38.410, P < 0.001; Immature
vs clear: t = 4.181, P < 0.001 and mature vs clear: t =
18.669, P < 0.001). The granuloma size of each category
remained homogeneous between the different time
points analysed.
The number and category of hepatic granulomas var-
ied among the three time points (Fig. 2). At 15 dpi, 75%
of granulomas were immature, with no clear granulomas
being observed. At 35 dpi, the total number of granu-
lomas increased by 40% compared to 15 dpi. In this case,
57% of granulomas were mature and almost 4% had
begun to be resolved (clear granulomas). At 63 dpi, the
total number of granulomas was reduced by 30% in
comparison with 35 dpi, with 62% of mature granulomas
and almost 17% of clear granulomas.
Immunohistochemistry
Detection of Leishmania spp. antigen
A specific and strong positive signal was observed for
amastigotes inside Kupffer cells in the liver (Fig. 1d).
Kupffer cells (F4/80+) and iNOS+ cells
Immunohistochemistry (IHC) for F4/80 was used to
locate Kupffer cells in the liver. A decrease in the ex-
pression of F4/80 was observed as the granuloma cat-
egory evolved within the same time point. However, a
statistically significant increase in the expression of
F4/80 was noted when immature and mature granu-
lomas were compared across the different time points
(15 vs 35 dpi, immature: t = -3.291, P < 0.001 and
mature: t = -2.202, P < 0.029; 15 vs 63 dpi, immature:
t = -5.691, P < 0.001 and mature: t = -4.335, P < 0.001)
There were no differences in the expression of F4/80
observed for clear granulomas when animals eutha-
nized at 35 and 63 dpi were compared. The highest
expression of F4/80 was found in immature granulomas,
regardless of the time point analyzed (Fig. 3). Distribution
of F4/80+ cells within granulomas was characterized by a
strong signal in Kupffer cells situated at the periphery of
granulomas and a lighter signal in fused Kupffer cells
containing L. donovani amastigotes in the centre of the
granuloma (Fig. 3).
Immunohistochemical staining for iNOS also showed
a higher mean percentage staining in immature
granulomas, regardless of the time point. As occurred
Fig. 1 a H&E-stained liver section 15 dpi (400×). Kupffer cell harbouring a high amount of amastigotes (arrowhead). Immature granulomas formed by
fused macrophages harbouring few amastigotes (arrows). Well-formed mature granuloma with a complete cellular infiltrate (*). b H&E-stained liver section
35 dpi (400×). Mature functional granuloma with few fused macrophages harbouring very few amastigotes (*). Clear granuloma without amastigotes and
with presence of collagen deposition (arrow). c H&E-stained liver section 63 dpi (400×). Clear granuloma composed mainly of lymphocytes (arrow).
d Immunohistochemical detection of Leishmania donovani antigens (400×). Immature granulomas harbouring a high amount of amastigotes (arrows)
and mature granulomas with fewer number of amastigotes (*). Scale-bars: 100 μm
Table 2 Mean size of granulomas per category
Granuloma category Mean size (μm2) Number (n) SD Error
Immature 30,434.05* 1061 13,471.478 413.578
Mature 66,612.02* 1238 28,030.675 796.660
Clear 25,925.49* 168 9323.050 719.289
Abbreviation: SD standard deviation
*P < 0.001, when mean size is compared among the three
granuloma categories
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for F4/80+ immunostaining, there was a decrease in
the expression of iNOS as the granuloma categories
evolved within the same time point. However, com-
pared with F4/80+ cells, the highest expression of
iNOS was observed at 35 dpi and not at 63 dpi. In fact,
there was a statistically significant reduction in the ex-
pression of iNOS for the three granuloma categories at
63 dpi, when compared to 35 dpi (immature: t = 4.589,
P < 0.001; mature: t = 10.520, P < 0.001; clear: t = 8.653,
P < 0.001) (Fig. 3). Positive staining for iNOS was
Fig. 2 Distribution (total numbers and percentages) of hepatic granulomas induced by Leishmania donovani divided into category 1 (immature),
category 2 (mature) and category 3 (clear) at three different time points (15 dpi, 35 dpi and 63 dpi)
Fig. 3 Immunohistochemical detection of macrophages (F4/80+) within hepatic granulomas at 15 dpi (a), 35 dpi (b) and 63 dpi (c). d Percentage
of immunostained area for F4/80 at 15, 35 and 63 dpi within immature (I), mature (M) and clear (C) granulomas. Immunohistochemical detection
of iNOS+ cells at 15 dpi (e), 35 dpi (f) and 63 dpi (g). h Percentage of immunostained area for iNOS at 15, 35 and 63 dpi within immature (I),
mature (M) and clear (C) granulomas. *P < 0.05. Scale-bars: 50 μm
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mainly observed in the cytoplasm of fused Kupffer
cells in the centre of the granuloma and was especially
marked in immature granulomas (Fig. 3).
T lymphocytes (CD3+)
An increase in the expression of CD3 was noted as
granuloma categories evolved in animals at 35 and 63
dpi, while a reduction was observed at 15 dpi. The
highest expression of CD3 was observed in animals eu-
thanized at 63 dpi. The only statistically significant dif-
ferences were observed when comparing mature
granulomas between animals euthanized at 35 and 63
dpi (t = -2.071, P < 0.001) and immature granulomas at
15 and 35 dpi (t = 3.507, P < 0.001) (Fig. 4). Distribution
of CD3+ cells was similar within granuloma categories
and time points. CD3+ cells were dispersed in the cellu-
lar infiltrate surrounding the fused Kupffer cells situated
in the granuloma centre (Fig. 4).
B lymphocytes (CD45R-B220+)
Immunohistochemical staining for CD45R-B220
showed the location of B lymphocytes within the granu-
loma. An increase in the expression of CD45R-B220
was observed as granuloma categories evolved within
the same time point (Fig. 4). When comparing granu-
lomas from mice euthanized at 15 and 35 dpi, a statisti-
cally significant reduction in the expression of CD45R-
B220 was observed for immature granulomas (t = 2.029,
P < 0.043), while a statistically significant increase was
observed for mature granulomas (t = -2.213, P < 0.027).
The expression of CD45R-B220 in mature granulomas
was quite homogeneous when comparing mice eutha-
nized at 35 and 63 dpi (Fig. 4). Most of the cells shap-
ing the cellular infiltrate surrounding the fused Kupffer
cells were CD45R-B220+ cells when compared with
CD3+ cells (Fig. 4).
Neutrophils (Ly-6G+)
The expression of Ly-6G within granulomas was
higher in mature compared to immature and clear
granulomas. Within mature granulomas a significantly
higher expression of Ly-6G was observed at 15 dpi
when compared to 35 dpi (t = 3.019, P < 0.043) and 63
dpi (t = 4.034, P < 0.035). In clear granulomas, neutro-
phils were only observed occasionally. The expression of
Ly-6G was generally lower compared to the other studied
cell markers, particularly at later time points (Fig. 4).
Fig. 4 Immunohistochemical detection of CD3+ T cells within hepatic granulomas at 15 dpi (a), 35 dpi (b) and 63 (c) dpi. d Percentage of
immunostained area for CD3 at 15, 35 and 63 dpi within immature (I), mature (M) and clear (C) granulomas. Immunohistochemical detection of CD45R/
B220+ cells (B cells) at 15 dpi (e), 35 dpi (f) and 63 dpi (g). h Percentage of immunostained area for CD45R/B220 at 15, 35 and 63 dpi within immature
(I), mature (M) and clear (C) granulomas. Immunohistochemical detection of Ly6G+ cells (neutrophils) at 15 dpi (i), 35 dpi (j) and 63 dpi (k). l Percentage
of immunostained area for Ly6G at 15, 35 and 63 dpi within immature (I), mature (M) and clear (C) granulomas. *P < 0.05. Scale-bars: 50 μm
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Discussion
The histopathological hallmark of hepatic resistance to vis-
ceralizing species of Leishmania is the development of
functional granulomas [10, 11, 14]. Here we used IHC as a
tool to characterise the different cells involved in the
hepatic granuloma development at different stages of ex-
perimental VL in BALB/c mice, complemented by quanti-
tative image analysis and detection of Leishmania antigen.
Immunohistochemical methods described here are a
powerful tool to characterise host responses to infection
in situ in mouse models of Leishmania spp. infection.
These have also been used in other granulomatous dis-
eases that share some, though not all properties with VL
[15–18]. Additionally these techniques can be utilised to
evaluate the cellular mechanism of new vaccines, drugs
and treatment regimens [19–21]. Therefore this study
provides in depth insights into the cellular dynamics of ex-
perimental VL in a context relevant to advancing health.
In agreement with previous studies [22, 23], we ob-
served that the majority of hepatic granulomas at 15 dpi
were immature, with a heavy presence of amastigotes.
Early amastigote replication in tissue macrophages is
regulated by the phagosomal proton-cation antiporter
encoded by the Slc11a1 gene (formerly Nramp1), and
high amastigote loads in the livers of BALB/c mice have
been linked to mutations in the Slc11a1 gene [24–27].
Control of hepatic parasite growth at later stages of in-
fection corresponds to the development of acquired
immune mechanisms [27, 28]. The increase in the
percentage of mature granulomas and the appearance of
clear granulomas at 35 and 63 dpi reflect the onset of
acquired immune responses and disease control, as the
leishmanicidal efficacy of hepatic granulomas is
dependent on their degree of maturation [23, 29]. In this
sense, it has been proposed that determining the degree
of maturation of hepatic granulomas constitutes an
effective tool for selecting VL vaccine candidates [30].
We also observed significant differences in hepatic
granuloma sizes between categories, possibly linked to
differences in the cellular composition of respective
granulomas in each category. Immature granulomas are
shaped by the presence of phagocytic cells, whereas ma-
ture granulomas contain higher numbers of lympho-
cytes, as observed by immunohistochemical detection of
T and B cells. Clear granulomas are smaller than mature
granulomas and contain less F4/80+ cells.
The highest expression of F4/80 found in immature
granulomas and the decrease in the expression of F4/80
observed as the granuloma category evolved within the
same time point, reflect that resident macrophages are the
first line of defence against Leishmania parasites within
this tissue. Moreover, monocytes are recruited into the
granuloma by chemokines (CCL3, CCL2 and CXCL10)
secreted by Kupffer cells infected with the parasite [27].
Similarly to F4/80+ cells, immunohistochemical stain-
ing for iNOS showed a higher mean percentage staining
in immature granulomas regardless of the time point,
and there was a decrease in the expression of iNOS as
the granuloma categories evolved within the same time
point. Hepatic resistance against L. donovani infection
correlates well with the generation of reactive oxygen
and reactive nitrogen intermediates [12]. Macrophages
are the main producers of iNOS, especially when acti-
vated by the intervention of T lymphocytes. Nitric oxide
produced by iNOS is believed to be of prime importance
in the cure of murine leishmaniasis, and in activating
murine macrophages to kill intracellular parasites [31].
This has been illustrated by studies of iNOS gene knock-
out mice, which do not self-resolve infection [32]. The
statistically significant reduction in the expression of
iNOS for the three granuloma categories at 63 dpi, when
compared to 35 dpi, may be related to the presence of
lower numbers of Leishmania amastigotes in the liver at
this phase of infection. The course of infection in BALB/
c mice infected with the L. donovani strain used here is
well documented [33, 34]. An increase in hepatic para-
site burden is observed until amastigote growth is con-
trolled around 28 dpi, followed by clearance of parasites
at later time points. In our study, complete absence of
Leishmania amastigotes was not observed by 63 dpi. It
has previously been reported that sterile immunity in
the liver is not achieved, but the presence of a residual
parasite population is thought to incite a small but en-
during immune response that provides long-term im-
munity to reinfection [27].
Expression of CD3 was lower at 15 dpi and in-
creased as granuloma categories evolved at 35 and 63
dpi. The highest expression of CD3 was observed at
the last time point, which is in agreement with the
continuous maturation of hepatic granulomas. Gene
knockout and antibody neutralization studies showed
that granuloma maturation in the liver of infected
mice requires CD4 and CD8 T cells and pro-
inflammatory cytokines such as IL-12, IFN-g and IL-2
to be functional [29, 35, 36].
Most of the cells that shaped the cellular infiltrate sur-
rounding the fused Kupffer cells were CD45R-B220+
cells and the expression of this marker increased as the
granuloma categories evolved within each time point. B
cells have previously been observed in hepatic granu-
lomas of L. donovani infected BALB/c mice [35] and
have been shown to accumulate in hepatic granulomas
in infected mice over time, exhibiting a highly motile be-
haviour [37]. They play a role in preventing liver path-
ology via control of neutrophil infiltration [38]. The
increase of CD45R-B220+ cells over time is also related
to the establishment of acquired immunity during the
maturation process of granulomas [14].
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The number of Ly6G+ neutrophils within the hepatic
granulomas was low and this cell population was mainly
observed in mature granulomas at all time points. Previ-
ous studies have demonstrated protective effects of neu-
trophils in livers of L. donovani infected mice and small
numbers of infiltrating neutrophils have been observed in
granulomas at 14 dpi [38, 39]. A contribution of neutro-
phils to the maturation of functional hepatic granulomas
and induction of hepatic iNOS has been suggested [39].
Conclusions
We observed that hepatic lesions start as a basic fusion
of Kupffer cells, producing high levels of iNOS, and
move to a more complex granuloma, related to an adap-
tive immune response with the presence of higher num-
bers of B and T lymphocytes and a final resolution
towards collagen deposition. The analyses described
here, based on infection with an established laboratory
strain of L. donovani, can be applied to other host-
parasite combinations, including genetically manipulated
parasites and recent clinical isolates. The panel of cellu-
lar markers can be extended to include other, less-
studied cell types. Paraffin blocks from this study have
been archived and are available for future analysis.
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